Mirion Technologies, Inc. (NYSE:MIR) Shares Sold by Schwartz Investment Counsel Inc.

Schwartz Investment Counsel Inc. lowered its stake in shares of Mirion Technologies, Inc. (NYSE:MIR - Free Report) by 11.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,349,300 shares of the company's stock after selling 170,000 shares during the period. Schwartz Investment Counsel Inc. owned 0.58% of Mirion Technologies worth $23,545,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. Exchange Traded Concepts LLC increased its position in shares of Mirion Technologies by 90.5% during the third quarter. Exchange Traded Concepts LLC now owns 22,698 shares of the company's stock worth $251,000 after purchasing an additional 10,781 shares in the last quarter. Integrated Advisors Network LLC acquired a new position in shares of Mirion Technologies during the third quarter worth $120,000. Roubaix Capital LLC acquired a new position in shares of Mirion Technologies during the third quarter worth $4,263,000. Rice Hall James & Associates LLC increased its position in shares of Mirion Technologies by 59.4% during the third quarter. Rice Hall James & Associates LLC now owns 352,737 shares of the company's stock worth $3,905,000 after purchasing an additional 131,453 shares in the last quarter. Finally, State of New Jersey Common Pension Fund D increased its position in shares of Mirion Technologies by 2.3% during the third quarter. State of New Jersey Common Pension Fund D now owns 179,998 shares of the company's stock worth $1,993,000 after purchasing an additional 4,043 shares in the last quarter. Hedge funds and other institutional investors own 78.51% of the company's stock.

Mirion Technologies Price Performance

Shares of NYSE:MIR traded up $0.07 during trading on Friday, reaching $16.32. 2,394,753 shares of the company's stock traded hands, compared to its average volume of 2,027,972. Mirion Technologies, Inc. has a fifty-two week low of $9.11 and a fifty-two week high of $18.81. The company has a quick ratio of 1.55, a current ratio of 2.16 and a debt-to-equity ratio of 0.43. The firm has a market cap of $3.79 billion, a PE ratio of -48.01 and a beta of 0.73. The company has a 50-day simple moving average of $16.95 and a 200-day simple moving average of $14.10.

Mirion Technologies (NYSE:MIR - Get Free Report) last posted its earnings results on Tuesday, February 11th. The company reported $0.16 EPS for the quarter, beating analysts' consensus estimates of $0.14 by $0.02. Mirion Technologies had a positive return on equity of 4.33% and a negative net margin of 7.84%. As a group, analysts predict that Mirion Technologies, Inc. will post 0.33 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on MIR. Baird R W raised Mirion Technologies to a "strong-buy" rating in a research report on Thursday, December 19th. The Goldman Sachs Group upped their target price on Mirion Technologies from $16.00 to $21.00 and gave the company a "buy" rating in a research report on Thursday, December 12th. Citigroup upped their target price on Mirion Technologies from $18.00 to $20.00 and gave the company a "buy" rating in a research report on Wednesday, December 4th. Finally, Robert W. Baird began coverage on Mirion Technologies in a research report on Thursday, December 19th. They issued an "outperform" rating and a $22.00 target price on the stock. Three equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Buy" and an average target price of $19.25.

Mirion Technologies Profile

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.